What changed from existing technology?
This study used computer analysis and lab experiments to find important genes related to exosomes in a type of throat cancer called nasopharyngeal carcinoma.
This is the first study to combine machine learning with experimental validation to identify key exosome-related genes in nasopharyngeal carcinoma.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 1
) signatures and their immunological relevance in NPC remains limited. This study systematically identified and validated key ERGs in NPC through integra
Abstract ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
- 장기·실사용 검증 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Validation stage
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
These findings may help in developing targeted therapies for nasopharyngeal carcinoma by understanding the role of exosome-related genes.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.